Gordon, K., Papp, K., Gooderham, M., Morita, A., Foley, P., Tha?i, D., Kundu, S., Kisa, R., Wei, L., & Banergee, S. (2020). BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients. SKIN The Journal of Cutaneous Medicine, 4(5), s28. https://doi.org/10.25251/skin.4.supp.28